Neuromuscular electrical stimulation for a patient with metastatic lung cancer--a case report.
A 47-year-old female patient suffering from advanced lung cancer with metastatic bone and brain disease participated in a passive exercise program, consisting of neuromuscular electrical stimulation (NMES) five times a week, carried out for 4 weeks. After the training period, the results of the 6-min walk (420 m before and 603 m after the training period) have improved by 44%, which demonstrates the increase of physical performance (mobility, endurance capacity). The results of the "Timed up and go" indicate an improvement of mobility and functional health of skeletal muscles. Furthermore, the quality of life (QOL)-scales (assessed by using the SF-36 health survey) "Physical functioning", "Role-physical", "Mental health", "Role-emotional", "Vitality", "Bodily pain", and "General health" showed improvements after the intervention period. Feasibility, safety, and beneficial effects of the NMES program were proven for the patient in this case study. These findings indicate that NMES, initiated and executed with appropriate care, may serve as a useful supportive means of palliative treatment in some patients with advanced cancer and metastatic disease, especially in cases of metastatic involvement of the brain and of the skeletal system with the risk of seizures and pathological fractures where volitional training is not allowed.
Crevenna
Richard
R
Department of Physical Medicine and Rehabilitation, Vienna Medical University, Waehringer Guertel 18-20, A-1090, Vienna, Austria. richard.crevenna@meduniwien.ac.at
Marosi
Christine
C
Schmidinger
Manuela
M
Fialka-Moser
Veronika
V
D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D001932:Brain Neoplasms / Q000556:secondary / Q000628:therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000503:physiopathology / Q000556:secondary* / Q000628:therapy*; D004599:Electric Stimulation Therapy; D005081:Exercise Therapy; D017079:Exercise Tolerance; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D008175:Lung Neoplasms / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy*; D008875:Middle Aged; D051346:Mobility Limitation; D053580:Muscle Strength; D018482:Muscle, Skeletal / Q000503:physiopathology; D010166:Palliative Care / Q000379:methods*; D010807:Physical Endurance; D011788:Quality of Life